Go to the list of all blogs
Alicia's Avatar
published in Blogs
May 04, 2026
ASX Limited (ASX): +17% Gain in 30 Days Amid CHESS Upgrade Progress

ASX Limited (ASX): +17% Gain in 30 Days Amid CHESS Upgrade Progress

Key Takeaways

  • ASX Limited stock rose approximately +17% over the past 30 days, driven by progress on the CHESS (Clearing House Electronic Subregister System) upgrade and resolution of regulatory concerns.
  • Over the past quarter, the stock gained around +10%, recovering from earlier lows amid higher trading volumes and strong revenue growth reported in half-year earnings.
  • Key catalysts include the appointment of an interim CEO, confirmation that CHESS Release 1 is ready for deployment, and positive market activity boosting cash market trading revenues.
  • Regulatory scrutiny from ASIC eased with ASX's Commitments plan, supporting sentiment shift; expenses rose but underlying NPAT grew 3.9% in 1H26.
  • Higher volatility in early April gave way to steady upward momentum, outperforming the S&P/ASX 200 benchmark YTD (22.45% vs. 0.20%).

Understanding ASX Limited and Its Strong Market Position

ASX Limited operates Australia's primary securities exchange, offering a vertically integrated platform for listings, trading, clearing, settlement, and related services across equities, derivatives, and debt markets. Its core business model draws revenue from trading fees, clearing and settlement (including the legacy CHESS system), data services, and issuer services like listings and registry operations. As a near-monopoly in the Australian market, ASX benefits from network effects and high barriers to entry, with exposure to overall market volumes and capital raisings. In my view, these fundamentals explain its resilience—rising trading activity directly lifts revenues, which has supported the recent price recovery amid improved market sentiment and operational milestones.

ASX Stock Price Action: 30 Days and the Past Quarter

Over the last 30 days, ASX Limited's stock price climbed from around 52.80 in early April to 61.82 as of May 4, marking a gain of approximately +17%. The movement was volatile initially, with a sharp rebound from April 7 lows (52.80) through mid-April spikes exceeding 6% daily, transitioning to steady gains into late April and early May, culminating in closes near 61.58 by May 1.

For the past quarter (early February to May), the stock advanced about +10%, from roughly 56.00 to 61.82. It experienced dips to 52.77 by early April amid broader pressures, followed by a robust trend-driven recovery, supported by higher volumes and outpacing the S&P/ASX 200. Overall, performance shifted from range-bound in March to upward momentum, reflecting reduced downside risks. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Key Drivers Behind the 30-Day Rally in ASX Stock

The 30-day surge stemmed primarily from operational progress on the CHESS upgrade, with ASX confirming on April 20 that Release 1—the replacement for its three-decade-old settlement system—is ready for market open. This milestone alleviated investor concerns over prior delays and outages, sparking a sentiment shift. On April 30, the appointment of Darren Yip as interim CEO provided leadership stability following Helen Lofthouse's planned May departure, further bolstering confidence.

Stronger market activity drove revenue, as cash market trading volumes rose, contributing to 24.6% growth in related fees per recent reports. A revised S&P credit rating in mid-April signaled financial resilience despite rising costs. Analyst sentiment improved with focus on diversified revenue streams, while broader ASX 200 stability amid volatility supported the upward trend, with daily gains accelerating post-CHESS news. From what I see, this combination has been crucial in shifting the narrative.

Quarterly Performance: Recovery from Headwinds

The quarterly +10% gain reflected recovery from regulatory headwinds, anchored by February's half-year results showing 11.2% operating revenue growth to $602.8 million, driven by elevated cash market trading (up 24.6%), futures volumes (up 10.5%), and Austraclear debt activity (up 14.4%). Underlying NPAT rose 3.9% to $263.6 million, though expenses jumped 20% due to ASIC inquiry costs, transformation programs like Accelerate, and CHESS investments.

ASIC's interim report and $150 million capital charge weighed early, prompting CEO transition and governance reforms, including independent CS facility boards. Macro factors like market volatility boosted derivatives trading, while new products (gold ETF options, environmental futures) enhanced positioning. Institutional focus on ASX's monopoly-like status and YTD outperformance vs. the benchmark sustained the rebound, with cumulative impacts from resolved risks outweighing cost pressures. One thing that stands out is how trading volumes have consistently supported the bottom line.

Trending AI Robots

In my trading research, I often turn to Tickeron’s Trending AI Robots page, which showcases the platform's top-performing AI-driven trading bots from a library of hundreds that analyze and trade thousands of tickers across various markets. These curated bots highlight those with the strongest recent results, adapting strategies like momentum, mean reversion, or pattern recognition over short-term, swing, or long-term timeframes. Performance metrics such as win rate, profit factor, and drawdown provide transparency, helping users identify relevant tools for stocks like ASX. Whether seeking high-frequency scalpers or trend-followers, the section filters for relevance and reliability. I find it valuable for integrating advanced automation into strategies, and it’s worth exploring for anyone following similar names.

What to Watch Next for ASX Stock

Investors should monitor the full rollout of CHESS Release 1 and any implementation hiccups, alongside ASIC's final inquiry report and ASX's Commitments plan execution. Upcoming full-year earnings will detail expense trends post-inquiry and revenue from new products. Industry developments like IPO pipelines and secondary raisings ($27.3 billion net new capital in 1H26) remain key amid interest rate sensitivity. Macro factors including RBA policy, market volatility, and global risk sentiment could influence trading volumes. Strategic shifts under new permanent CEO leadership, governance enhancements for clearing facilities, and competitive dynamics from potential rivals like Cboe warrant attention. Risks include further regulatory fines or system outages, balanced by catalysts like dividend policy (recently adjusted to 75-85% payout) and credit rating stability. I’m watching this closely, particularly the CHESS deployment.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.

Related Ticker: ASX

Contributor

Alicia's AvatarAlicia|Beginner

ASX in upward trend: price may ascend as a result of having broken its lower Bollinger Band on July 28, 2026

ASX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 34 cases where ASX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ASX's RSI Indicator exited the oversold zone, of 19 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ASX advanced for three days, in of 345 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ASX as a result. In of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ASX turned negative on August 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

ASX moved below its 50-day moving average on August 18, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ASX crossed bearishly below the 50-day moving average on July 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ASX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ASX entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ASX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.776) is normal, around the industry mean (7.465). P/E Ratio (44.547) is within average values for comparable stocks, (155.851). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.777). Dividend Yield (0.011) settles around the average of (0.015) among similar stocks. P/S Ratio (3.659) is also within normal values, averaging (53.922).

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Taiwan Semiconductor Manufacturing Company Ltd (NYSE:TSM), Broadcom Inc. (NASDAQ:AVGO), Micron Technology (NASDAQ:MU), Advanced Micro Devices (NASDAQ:AMD), Intel Corp (NASDAQ:INTC), Texas Instruments (NASDAQ:TXN), Marvell Technology (NASDAQ:MRVL), Analog Devices (NASDAQ:ADI), QUALCOMM (NASDAQ:QCOM).

Industry description

The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.

Market Cap

The average market capitalization across the Semiconductors Industry is 196.39B. The market cap for tickers in the group ranges from 13.43K to 5.2T. NVDA holds the highest valuation in this group at 5.2T. The lowest valued company is CYBL at 13.43K.

High and low price notable news

The average weekly price growth across all stocks in the Semiconductors Industry was -8%. For the same Industry, the average monthly price growth was -7%, and the average quarterly price growth was 37%. ICG experienced the highest price growth at 16%, while MXL experienced the biggest fall at -21%.

Volume

The average weekly volume growth across all stocks in the Semiconductors Industry was -9%. For the same stocks of the Industry, the average monthly volume growth was -12% and the average quarterly volume growth was -52%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 55
Price Growth Rating: 52
SMR Rating: 74
Profit Risk Rating: 75
Seasonality Score: -24 (-100 ... +100)
View a ticker or compare two or three
ASX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a holding company providing semiconductor manufacturing services

Industry Semiconductors

Profile
Details
Industry
Semiconductors
Address
No. 26, Chin Third Road
Phone
+886 73617131
Employees
101981
Web
https://www.aseglobal.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.